Adult ADHD and Substance Abuse: Diagnostic and Treatment Issues

References

• Adler L. A., Kessler R. C., Spencer T. Adult ADHD Self-Report Scale-v1.1 (ASRS-v1.1) Symptom Checklist. World Health Organization, New York, NY 2003, http://www.med.nyu.edu/ Psych/training/adhd.html Accessed April 8, 2004.
   Google Scholar
• Adler L. A., Resnick S., Kunz M., Devinsky O. Open-label trial of venlafaxine in adults with attention-deficit disorder. Psychopharmacol Bulletin 1995; 31(4)785–758
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, version III. American Psychiatric Press, Washington, DC 1980
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, version III-R. American Psychiatric Press, Washington, DC 1987
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, version IV. American Psychiatric Press, Washington, DC 1994
   Google Scholar
• Armstrong C. L., Hayes K. M., Martin R. Neurocognitive problems in attention deficit disorder. Alternative concepts and evidence for impairment in inhibition of selective attention. Annals of the New York Academy of Sciences 2001; 931: 196–215, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Aviram R. B., Rhum M., Levin F. R. Psychotherapy of adults with comorbid attention-deficit/ hyperactivity disorder and psychoactive substance use disorder. Journal of Psychotherapy Practice and Research 2001; 10(3)179–186, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Barkley R. Taking Charge of ADHD: The Complete Authoritative Guide for Parents. Guilford Press, New York 1995
   Google Scholar
• Barkley R. A. A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry 1977; 18(2)137–165, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Barkley R. A. Advancing age, declining ADHD. American Journal of Psychiatry 1997; 154(9)1323–1325, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Barkley R. A., Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. Journal of American Academy of Child and Adolescent Psychiatry 1997; 36(9)1204–1210, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Beurrier C., Malenka R. C. Enhanced inhibition of synaptic transmission by dopamine in the nucleus accumbens during behavioral sensitization to cocaine. Journal of Neuroscience 2002; 22(14)5817–5822, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Biederman J. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. Journal of Clinical Psychiatry 2003; 64(11)3–8, Suppl.[PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Biederman J. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry 2004; 65(Suppl. 3)3–7, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Biederman J., Faraone S. V., Spencer T., Wilens T., Norman D., Lapey K. A., Mick E., Lehman B. K., Doyle A. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 1993; 150(12)1792–1798, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Biederman J., Mick E., Faraone S. V. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. American Journal of Psychiatry 2000; 157(5)816–818, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Biederman J., Wilens T., Mick E., Milberger S., Spencer T. J., Faraone S. V. Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry 1995; 152(11)1652–1658, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Biederman J., Wilens T., Mick E., Spencer T., Faraone S. V. Pharmacotherapy of attention-deficit hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104(2)20, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Brooks D. B., Kalbag A. S., Vosburg S. K., Evans S. M., Levin F. R. Assessment of Cognitive Functioning of Methadone-Maintenance Patients: Impact of Adult ADHD and Current Cocaine Dependence, (Manuscript submitted, 2005)
   Google Scholar
• Brown T. E. Brown Attention-Deficit Disorder Scales. The Psychological Corporation, San Antonio, TX 1996
   Google Scholar
• Bush G., Frazier J. A., Rauch S. L., Seidman L. J., Whalen P. H., Jenike M. A., Rosen B. R., Biederman J. Anterior cingulated cortex dysfunction in attention-deficit hyperactivity disorder revealed by fMRI and the counting stroop. Biological Psychiatry 1999; 45(12)1542–1552, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Carroll K. M., Rounsaville B. J. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry 1993; 34(2)75–82, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Carter C. S., Krener P., Chaderjian M., Northcutt C., Wolfe V. Asymmetrical visual-spatial attentional performance in ADHD: evidence for a right hemispheric deficit. Biological Psychiatry 1995; 37(11)789–797, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cavanagh R., Clifford J. S., Gregory W. L. The use of bromocriptine for the treatment of attention deficit disorder in two chemically dependent patients. Journal of Psychoactive Drugs 1989; 21(2)217–220, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Clure C., Brady K. T., Saladin M. E., Johnson D., Waid R., Rittenbury M. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. American Journal of Drug and Alcohol Abuse 1999; 25(3)441–448, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cocores J. A., Davies R. K., Mueller P. S., Gold M. S. Cocaine abuse and adult attention deficit disorder. Journal of Clinical Psychiatry 1987; 48(9)376–377, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Conners C. K., Erhart D., Sparrow E. Conners'Adult ADHD Rating Scales, Technical Manual. Multi-Health Systems, New York 1999
   Google Scholar
• Cook E. H., Jr., Stein M. A., Krasowski M. D., Cox N. J., Olkon D. M., Kieffer J. E., Leventhal B. L. Association of attention-deficit disorder and the dopamine transporter gene. American Journal of Human Genetics 1995; 56(4)993–998, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Dansereau D. F., Joe G. W., Simpson D. D. Attentional difficulties and the effectiveness of a visual representation strategy for counseling drug-addicted clients. International Journal of the Addictions 1995; 30(4)371–86, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Dupaul G., Power T., Anastopoulos A., Reid R. ADHD Rating Scale, IV: Checklists, Norms and Clinical Interpretation. Guilford Press, New York 1998
   Google Scholar
• Epstein J. N., Johnson D. E., Conners C. K. Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID). Multi-Health Systems Inc, North Tonawanda, NY 2001
   Google Scholar
• Ernst M., Zametkin A. J., Phillips R. L., Cohen R. M. Age-related changes in brain glucose metabolism in adults with attention-deficit hyperactivity disorder and control subjects. Journal of Neuropsychiatry and Clinical Neurosciences 1998; 10(2)168–177, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Eyre S. L., Rounsaville B. J., Kleber H. D. History of childhood hyperactivity in a clinic population of opiate addicts. Journal of Nervous and Mental Disease 1982; 170(9)522–529, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Faraone S. V., Biederman J., Spencer T., Wilens T., Seidman L. J., Mick E., Doyle A. E. Attention-deficit/ hyperactivity disorder in adults: an overview. Biological Psychiatry 2000; 48(1)9–20, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Faraone S. V., Biederman J., Weiffenbach B., Keith T., Chu M. P., Weaver A., Spencer T. J., Wilens T. E., Frazier J., Cleves M., Sakai J. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. American Journal of Psychiatry 1999; 156(5)768–770, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Findling R. L., Schwartz M. A., Flannery D. J., Manos M. J. Venlafaxine in adults with attention-deficit hyperactivity disorder an open clinical trial. Journal of Clinical Psychiatry 1996; 57(5)184–189, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Flory K., Milich R., Lynam D. R., Leukefeld C., Clayton R. Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of attention-deficit hyperactivity disorder and conduct disorder are uniquely at risk. Psychology of Addictive Behaviors 2003; 17(2)151–158, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gill M., Daly G., Heron S., Hawi Z., Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Molecular Psychiatry 1997; 2(4)311–313, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Gittleman R., Mannuzza S., Shenker R., Bonagura N. Hyperactive boys almost grown up. I. Psychiatric status. Archives of General Psychiatry 1985; 42(10)937–947
   PubMedGoogle Scholar
• Greenfield B., Hechtman L., Weiss G. Two subgroups of hyperactives as adults: correlations of outcome. Canadian Journal of Psychiatry 1988; 33(6)505–508
   PubMedGoogle Scholar
• Greenhill L. L. Pharmacologic treatment of attention deficit hyperactivity disorder. Psychiatric Clinics of North America 1992; 15(1)1–27, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Grodzinsky G. M., Barkley R. A. Predictive power of frontal lobe tests in the diagnosis of attention-deficit hyperactivity disorder. Archives of Clinical Neuropsychology 1999; 13(1)12–21
   Google Scholar
• Hechtman L., Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Pediatric Drugs 2003; 5(12)787–794, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hedges D., Reimherr F. W., Rogers A., Strong R., Wender P. H. An open trial of venlafaxine in adult patients with attention- deficit hyperactivity disorder. Psychopharmacol Bulletin 1995; 31(4)779–783
   PubMedGoogle Scholar
• Hesslinger B., Tebartz van Elst L., Nyberg E., Dykierek P., Richter H., Berner M., Ebert D. Psychotherapy of Attention deficit hyperactivity disorder in adults: a pilot study using a structured skills training program. European Archives of Psychiatry and Clinical Neuroscience 2002; 252(4)177–184, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hien D., Matzner F., First M., Spitzer R., Williams J., Gibbon M. The Structured Clinical Interview for DSM-IV, Childhood version (KID-SCID). 2001, Unpublished instrument, 2001 (revised)
   Google Scholar
• Higgins S. T., Budney, Bickel A. J., Foerg W. K., Donham F. E. R., Badger G. J. Incentives improve outcome in outpatient behavioral treatment for cocaine dependence. Archives of General Psychiatry 1994; 51(7)568–576, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hill J. C., Schoener E. P. Age-dependent decline of attention deficit hyperactivity disorder. American Journal of Psychiatry 1996; 153(9)1143–1146, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hoffman B. B., Lefkowitz R. J. Catecholamines, sympathomimetic drugs and adrenergic receptor agonists. Goodman & Gilman's The Pharmacological Basis of Therapeutics, J. G. Jardman, et al. McGraw-Hill, New York 1996; 199–263
   Google Scholar
• Horrigan J. P., Barnhill L. J. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry 2000; 61(6)414–417, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kalbag A. S., Brooks D. J., Evans S. M., Nunes E. V., Levin F. R. The relationship between the specific and non-specific ADHD symptoms and addiction severity in a methadone-maintained sample of adults with ADHD. Manuscript in preparation
   Google Scholar
• Kessler R. C., McGonagle K. A., Shao S., Nelson C. B., Hughes M., Eshleman S., Wittchen H. U., Kendler K. S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 1994; 51(1)8–19, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Khantzian E. J. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. American Journal of Psychiatry 1983; 140(6)784–785, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Khantzian E. J., Gawin F., Kleber H. D., Riordan C. E. Methylphenidate (Ritalin) treatment of cocaine dependence a preliminary report. Journal of Substance Abuse Treatment 1984; 1(2)107–112, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• King V. L., Brooner R. K., Kidorf M. S., Stoller K. B., Mirsky A. F. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. Journal of Nervous and Mental Disease 1999; 187(8)487–495, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kuperman S., Perry P., Gaffney G., Lund B., Bever-Stille K., Arndt S., Holman T. L., Moser D., Paulsen J. Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Annals of Clinical Psychiatry 2001; 13(3)129–134, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• LaHoste G. J., Swanson J. M., Wigal S. B., Glabe C., Wigal T., King N., Kennedy J. L. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry 1996; 1(2)121–124, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lambert N. M., Hartsough C. S. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. Journal of Learning Disabilities 1998; 31(6)533–544, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Levin F. R., Evans S. M., Kleber H. D. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence 1998; 52(1)15–25, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Levin F. R., Evans S. M., McDowell D. M., Brooks D. J., Nunes E. Bupropion treatment for cocaine and adult attention-deficit hyperactivity disorder. Journal of Addictive Disorders 2002; 21(2)1–16, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Levin F. R., Evans S. M., McDowell D. M., Kleber H. D. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. Journal of Clinical Psychiatry 1998; 59(6)300–305, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Levin F. R., Evans S. M., Vosburg S. K., Horton T., Brooks D., Ng J. Impact of attention deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addictive Behaviors 2004; 29(9)1875–1882, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Levin F. R., Kleber H. D. Attention-deficit hyperactivity disorder and substance abuse: relationship and implications for treatment. Harvard Review of Psychiatry 1995; 2(5)246–258, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Linehan M. M., Armstrong H. E., Suarez A., Allmon D., Heard H. L. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry 1991; 48(12)1060–1064, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Linehan M. M., Schmidt H., 3rd, Dimeff L. A., Craft J. C., Kanter J., Comtois K. A. Dialectical behavior therapy of patients with borderline personality disorder and drug-dependence. American Journal on Addictions 1999; 8(4)279–292, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lovejoy D. W., Ball J. D., Keats M., Stutts M. L., Spain E. H., Janda L., Janusz J. Neuropsychological performance of adults with attention-deficit hyperactivity disorder (ADHD): diagnostic classification estimates for measures of frontal lobe/executive functioning. J Int Neuropsychol Soc 1999; 5(3)222–233, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lowe N., Kirley A., Hawi Z., Sham P., Wickham H., Kratochvil C. J., Smith S. D., Lee S. Y., Levy F., Kent L., Middle F., Rohde L. A., Roman T., Tahir E., Yazgan Y., Asherson P., Mill J., Thapar A., Payton A., Todd R. D., Stephens T., Ebstein R. P., Manor I., Barr C. L., Wiggs K. G., Sinke R. J., Buitelaar J. K., Smalley S. L., Nelson S. F., Biederman J., Faraone S. V., Gill M. Joint analysis of the DRD5 marker concludes associations with attention-deficit hyperactivity disorder confined to the predominantly inattentive and combined subtypes. American Journal of Human Genetics 2004; 74(2)348–356, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Mannuzza S., Klein R. G. Long-term prognosis in attention-deficit hyperactivity disorder. Child and Adolescent Pediatric Clinics of North America 2000; 9(3)711–726
   PubMed Web of Science ®Google Scholar
• Mannuzza S., Klein R. G., Bessler A., Malloy P., Hynes M. E. Educational and occupational outcome of hyperactive boys grown up. Journal of American Academy of Child Adolescent Psychiatry 1997; 36(9)1222–1227, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mannuzza S., Klein R. G., Bessler A., Malloy P., LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Archives of General Psychiatry 1993; 50(7)565–576, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mannuzza S., Klein R. G., Bessler A., Malloy P., LaPadula M. Adult psychiatric status of hyperactive boys grown up. American Journal of Psychiatry 1998; 155(4)493–498, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mannuzza S., Klein R. G., Bonagura N., Malloy P., Giampino T. L., Addalli K. A. Hyperactive boys almost grown up. V. Replication of psychiatric status. Archives of General Psychiatry 1991; 48(1)77–83, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mannuzza S., Klein R. G., Moulton J. L. Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. Journal of Child and Adolescent Psychopharmacology 2003; 13(3)273–282, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mannuzza S., Klein R. G., Moulton J. L. Persistence of attention-deficit/hyperactivity disorder into adulthood: what have we learned from the prospective follow-up studies?. Journal of Attention Disorders 2003; 7(2)93–100, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mattes J. A., Boswell L., Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Archives of General Psychiatry 1984; 41(11)1059–1063, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Michelson D., Adler L., Spencer T., Reimherr F. W., West S. A., Allen A. J., Kelsey D., Wernicke J., Dietrich A., Milton D. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biological Psychiatry 2003; 53: 112–120, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Milberger S., Biederman J., Faraone S. V., Wilens T., Chu M. P. Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. American Journal on Addictions 1997; 6(4)318–329, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• MTA cooperative group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA cooperative group. Multimodal treatment study of children with ADHD. Archives of General Psychiatry 1999; 56(12)1073–1086, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Murphy K. R., Barkley R. A., Bush T. Young adults with attention-deficit hyperactivity disorder: subtype differences in comorbidity, educational and clinical history. Journal of Nervous and Mental Disease 2002; 190(3)147–157, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Niederhofer H. An open trial of busiprone in the treatment of attention-deficit disorder. Human Psychopharmacology 2003; 18(6)489–492, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Orvaschel H. Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacol Bulletin 1985; 21(4)737–745
   PubMedGoogle Scholar
• Paternite C. E., Loney J., Salisbury H., Whaley M. A. Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. Journal of Child and Adolescent Psychopharmacology 1999; 9(3)169–184, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Paterson R., Douglas C., Hallmayer J., Hagan M., Krupenia Z. A randomized, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry 1999; 33(4)494–502, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pelham W. E., Sams S. E. Behavior modification. Child and Adolescent Psychiatric Clinics of North America, G Weiss. W. B. Saunders, Philadelphia, PA 1992; 505–518
   Google Scholar
• Pomeraleau O. F., Downey K. K., Stelson F. W., Pomeraleau C. S. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. Journal of Substance Abuse 1995; 7(3)373–378, [CROSSREF]
   PubMedGoogle Scholar
• Regier D. A., Farmer M. E., Rae D. S., Locke B. Z., Keith S. J., Judd L. L., Goodwin F. K. Comorbidity of mental disorders with alcohol and other drug abuse. Results form the Epidemiologic Catchment Area (ECA) Study. Journal of American Medical Association 1990; 264(19)2511–2518, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rounsaville B. J., Anton S. F., Carroll K., Budde D., Prusoff B. A., Gawin F. Psychiatric diagnosis of treatment-seeking cocaine abusers. Archives of General Psychiatry 1991; 48(1)43–51, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rubia K., Overmeyer S., Taylor E., Brammer M., Williams S. C., Simons A., Bullmore E. T. Hyprofrontality in attention-deficit hyperactivity disorder during higher-order motor control, a study with functional MRI. American Journal of Psychiatry 1999; 156(6)891–896, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rugino T. A., Samsock T. C. Modafinil in children with attention-deficit hyperactivity disorder. Pediatric Neurology 2003; 29(2)136–142, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schubiner H., Saules K. K., Arfken C. L., Johanson C. E., Schuster C. R., Lockhart N., Edwards A., Donlin J., Philgren E. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology 2000; 10(3)286–294, [CROSSREF]
   Google Scholar
• Schweitzer J. B., Faber T. L., Grafton S. T., Tune L. E., Hoffman J. M., Kilts C. D. Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. American Journal of Psychiatry 2000; 157(2)278–280, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Seidman L. J., Biederman J., Weber W., Hatch M., Faraone S. V. Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biological Psychiatry 1998; 44(4)260–268, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sohlberg M. M., Mateer C. A. Improving attention and managing attentional problems. Adapting rehabilitation techniques to adults with ADD. Annals of the New York Academy of Sciences 2001; 931: 359–375, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Somoza E., Bridge P., Winhusen T., Rotrosen J., Vanderburg D., Harrer J., Mezinskis J., Montgomery A., Leiderman D., Locastro J., Wulsin L., Barrett J. An open-label pilot study of methylphenidate in the treatment of cocaine-dependence patients with attention deficit hyperactivity disorder. Drug and Alcohol Dependence 2000; 60(1)S208
   Google Scholar
• Spencer T., Biederman J., Wilens T., Faraone S., Prince J., Gerard K., Doyle R., Parekh A., Kagan J., Bearman S. K. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit hyperactivity disorder. Archives of General Psychiatry 2001; 58(8)775–782, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Spencer T., Biederman J., Wilens T., Prince J., Hatch M., Jones J., Harding M., Faraone S. V., Seidman L. Effectiveness and tolerability of tomoxetine in adults with attention-deficit hyperactivity disorder. American Journal of Psychiatry 1998; 155(5)693–695, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Spencer T., Wilens T., Biederman J., Faraone S. V., Ablon J. S., Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Archives of General Psychiatry 1995; 52(6)434–443, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stevenson C. S., Whitmont S., Bornholt L., Livesey D., Stevenson R. J. A cognitive remediation programme for adults with attention-deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry 2002; 36(5)610–616, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sullivan M., Levin F. R. Attention deficit/hyperactivity disorder and substance abuse: diagnostic and therapeutic considerations. Adult Attention Deficit Disorder: Brain Mechanisms and Life Outcomes, J. Wasserstein, L. E. Wolf, F. F. Lefever. Annals of the New York Academy of Sciences. 2001; 931: 251–270
   Google Scholar
• Szatmari P. The epidemiology of attention-deficit hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America, G. Weiss, 1992; 361–384
   Google Scholar
• Taylor F. B., Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. Journal of Child and Adolescent Psychopharmacology 2000; 10(4)311–320, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Taylor F., Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. Journal of Psychopharmacology 2001; 21(2)223–228, [CROSSREF]
   Google Scholar
• Thompson L. L., Riggs P. D., Mikulich S. K., Crowley T. J. Contribution and ADHD symptoms to substance problems and delinquency conduct-disordered adolescents. Journal of Abnormal Child Psychology 1996; 24(3)325–347, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Vaidya C. J., Austin G., Kirkorian G., Ridlehuber H. W., Desmond J. E., Glover G. H., Gabrieli J. D. Selective effects of methylphenidate in attention-deficit hyperactivity disorder: a functional magnetic resonance study. Proceeding of the National Academy of Sciences of the United States of America 1998; 95(24)14494–14499, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ward M. F., Wender P. H., Reimherr F. W. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry 1993; 150(6)885–890, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Weinstein C. S. Cognitive remediation strategies: an adjunct to the psychotherapy of adults with attention-deficit hyperactivity disorder. Journal of Psychotherapy Practice and Research 1994; 3: 44–57
   PubMedGoogle Scholar
• Weiss G., Hechtman L. T. Adult hyperactive subjects' view of their treatment in childhood and adolescence. Hyperactive Children Grown Up: Empirical Finding and Theoretical Considerations. Guilford, New York 1986; 293–300
   Google Scholar
• Weiss M., Hechtman L. T., Weiss G. ADHD in Adulthood: A Guide to Current Theory, Diagnosis, and Treatment. The Johns Hopkins University Press, Baltimore, MD 1999
   Google Scholar
• Wender P. H. Attention-Deficit Hyperactivity Disorder in Adults. Oxford University Press, New York 1995
   Google Scholar
• Wender P. H., Ward M. F., Reimherr F. W., Marchant B. K. ADHD in adults. Journal of American Academy of Child Adolescent Psychiatry 2000; 39(5)543, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• West S. L., Mulsow M., Arrendondo R. Factor analysis of attention deficit scales for adults (ADSA) in a clinical sample of outpatient substance abusers. American Journal on Addictions 2003; 12(2)159–165, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wilens T. E., Biederman J., Abrantes A. M., Spencer T. J. Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder. Journal of American Academy of Child Adolescent Psychiatry 1997; 36: 941–947, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wilens T. E., Biederman J., Prince J., Spencer T. J., Faraone S. V., Warburton R., Schleifer D., Harding M., Linehan C., Geller D. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. American Journal of Psychiatry 1996; 153(9)1147–1153, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wilens T. E., Biederman J., Spencer T. J. Venlafaxine for adult ADHD. American Journal of Psychiatry 1995; 152(7)1099–1100, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wilens T. E., Biederman J., Spencer T. J., Bostic J., Prince J., Monuteaux M. C., Soriano J., Fine C., Abrams A., Rater M., Polisner D. A pilot controlled clinical trial of ABT-418, a cholinergic agonist in the treatment of adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 1999; 156(12)1931–1937, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wilens T. E., Biederman J., Spencer T. J., Frazier J., Prince J., Bostic J., Rater M., Soriano J., Hatch M., Sienna M., Millstein R. B., Abrantes A. Controlled trial of high doses of pemoline for adults with attention deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology 1999; 19(3)257–264, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Wilens T. E., Biederman J., Spencer T. J., Prince J. Pharmacotherapy of adult attention deficit-hyperactivity disorder: a review. Journal of Clinical Psychopharmacology 1995; 15(4)270–279, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wilens T. E., Faraone S. V., Biederman J., Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003; 111(1)179–185, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wilens T. E., Spencer T. J., Biederman J., Girard K., Doyle R., Prince J., Polsiner D., Sohlkhah R., Comeau S., Monuteaux M. C., Parekh A. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. American Journal of Psychiatry 2001; 158(2)282–288, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wise B. K., Cuffe S. P., Fischer T. Dual Diagnosis and successful participation of adolescents in substance abuse treatment. Journal of Substance Abuse Treatment 2001; 1: 161–165, [CROSSREF]
   Google Scholar
• Wise R. A. Drug-activation of brain reward pathways. Drug and Alcohol Dependence 1998; 51(1–2)13–22, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wonnacott S., Irons J., Rapier C., Thorne B., Lunt G. G. Presynaptic modulation of transmitter release by nicotinic receptors. Progress in Brain Research 1989; 79: 157–163, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wood D., Wender P. H., Reimherr F. W. The prevalence of attention deficit disorder, residual type, or minimal brain dysfunction, in a population of male alcoholic patients. American Journal of Psychiatry 1983; 140(1)95–98, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Zametkin A. J., Liebenauer L. L., Fitzgerald G. A., King A. C., Minkunas D. V., Herscovitch P., Yamada E. M., Cohen R. M. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Archives of General Psychiatry 1993; 50(5)333–340, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Zametkin A. J., Nordahl T. E., Gross M., King A. C., Semple W. E., Rumsey J., Hamburger S., Cohen R. M. Cerebral glucose metabolism in adults with hyperactivity for childhood onset. New England Journal of Medicine 1990; 323(20)1361–1366, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar